Literature DB >> 25371966

Use of PER977 to reverse the anticoagulant effect of edoxaban.

Jack E Ansell1, Sasha H Bakhru, Bryan E Laulicht, Solomon S Steiner, Michael Grosso, Karen Brown, Victor Dishy, Robert J Noveck, James C Costin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25371966     DOI： 10.1056/NEJMc1411800

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  105 in total

Review 1.  The biochemistry, enzymology and pharmacology of non-vitamin K anticoagulant drug reversal agents and antidotes.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

Review 2.  Universal, class-specific and drug-specific reversal agents for the new oral anticoagulants.

Authors:  Jack E Ansell
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

3.  Antidotes for patients taking novel oral anti-coagulants.

Authors:  Stefanie W Yip; Yiu Che Chan
Journal:  World J Emerg Med       Date:  2015

4.  Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants.

Authors:  Nur A Rahmat; Gregory Y H Lip
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

Review 5.  Edoxaban in patients with atrial fibrillation.

Authors:  Alon Eisen; Christian T Ruff
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-08-01

6.  Italian intersociety consensus on DOAC use in internal medicine.

Authors:  Domenico Prisco; Walter Ageno; Cecilia Becattini; Armando D'Angelo; Giovanni Davì; Raimondo De Cristofaro; Francesco Dentali; Giovanni Di Minno; Anna Falanga; Gualberto Gussoni; Luca Masotti; Gualtiero Palareti; Pasquale Pignatelli; Roberto M Santi; Francesca Santilli; Mauro Silingardi; Antonella Tufano; Francesco Violi
Journal:  Intern Emerg Med       Date:  2017-02-13       Impact factor: 3.397

Review 7.  [Hemorrhage under direct oral anticoagulants : Occurrence and treatment in intensive care patients].

Authors:  H M Hoffmeister; H Darius; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-05-04       Impact factor: 0.840

Review 8.  Plasma contact factors as therapeutic targets.

Authors:  Benjamin F Tillman; Andras Gruber; Owen J T McCarty; David Gailani
Journal:  Blood Rev       Date:  2018-04-12       Impact factor: 8.250

Review 9.  Measurement and reversal of the direct oral anticoagulants.

Authors:  Bethany T Samuelson; Adam Cuker
Journal:  Blood Rev       Date:  2016-09-02       Impact factor: 8.250

Review 10.  Perioperative management of the bleeding patient.

Authors:  K Ghadimi; J H Levy; I J Welsby
Journal:  Br J Anaesth       Date:  2016-12       Impact factor: 9.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.